TW202404607A - 醫藥製劑之滅菌法與包裝體 - Google Patents

醫藥製劑之滅菌法與包裝體 Download PDF

Info

Publication number
TW202404607A
TW202404607A TW112111985A TW112111985A TW202404607A TW 202404607 A TW202404607 A TW 202404607A TW 112111985 A TW112111985 A TW 112111985A TW 112111985 A TW112111985 A TW 112111985A TW 202404607 A TW202404607 A TW 202404607A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
salt
aqueous pharmaceutical
diethylamino
methyl
Prior art date
Application number
TW112111985A
Other languages
English (en)
Chinese (zh)
Inventor
遠藤洋子
眞崎賢治
仙波久実
Original Assignee
日商參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商參天製藥股份有限公司 filed Critical 日商參天製藥股份有限公司
Publication of TW202404607A publication Critical patent/TW202404607A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hematology (AREA)
TW112111985A 2022-03-30 2023-03-29 醫藥製劑之滅菌法與包裝體 TW202404607A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022056765 2022-03-30
JP2022-056765 2022-03-30

Publications (1)

Publication Number Publication Date
TW202404607A true TW202404607A (zh) 2024-02-01

Family

ID=88202031

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112111985A TW202404607A (zh) 2022-03-30 2023-03-29 醫藥製劑之滅菌法與包裝體

Country Status (8)

Country Link
US (1) US20250213588A1 (cg-RX-API-DMAC7.html)
EP (1) EP4501329A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023190653A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240165977A (cg-RX-API-DMAC7.html)
CN (1) CN118946362A (cg-RX-API-DMAC7.html)
CA (1) CA3254890A1 (cg-RX-API-DMAC7.html)
TW (1) TW202404607A (cg-RX-API-DMAC7.html)
WO (1) WO2023190653A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250214992A1 (en) * 2022-03-30 2025-07-03 Santen Pharmaceutical Co., Ltd. High-purity compound production method and purification method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0318772A (ja) 1989-06-16 1991-01-28 Mitsubishi Cable Ind Ltd 絶縁体の絶緑性能評価方法
US5716952A (en) 1992-03-18 1998-02-10 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
US6291466B1 (en) * 1998-07-30 2001-09-18 Allergan Sales, Inc. Cholinergic agents in the treatment of presbyopia
WO2018039159A1 (en) * 2016-08-22 2018-03-01 Chase Pharmaceuticals Corporation Muscarinic m2-antagonist combination
EP4178948A2 (en) * 2020-07-29 2023-05-17 Universidade de Santiago de Compostela Functionalized isonitriles and products, preparation and uses thereof
CA3189821A1 (en) * 2020-08-04 2022-02-10 Santen Pharmaceutical Co., Ltd. Agent for treating myopia, preventing myopia and/or suppressing myopia progression
JP7253813B2 (ja) 2020-08-07 2023-04-07 株式会社ユニバーサルエンターテインメント 遊技機
KR20230087514A (ko) * 2020-10-14 2023-06-16 산텐 세이야꾸 가부시키가이샤 안정한 의약 조성물

Also Published As

Publication number Publication date
US20250213588A1 (en) 2025-07-03
CN118946362A (zh) 2024-11-12
JPWO2023190653A1 (cg-RX-API-DMAC7.html) 2023-10-05
KR20240165977A (ko) 2024-11-25
CA3254890A1 (en) 2025-04-09
EP4501329A1 (en) 2025-02-05
EP4501329A4 (en) 2026-03-25
WO2023190653A1 (ja) 2023-10-05

Similar Documents

Publication Publication Date Title
AU2016326572B2 (en) Lipoic acid choline ester compositions and methods to generate biocompatible ophthalmic formulations
JP2025129261A (ja) クロルヘキシジンを含有する医薬組成物
JP2022101629A (ja) 安定な医薬組成物
WO2023190653A1 (ja) 医薬製剤の滅菌法と包装体
JP7037349B2 (ja) 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) 水溶性粘稠化剤を含有する医薬組成物
JP6653037B2 (ja) 水性液剤
JP7378959B2 (ja) 眼科用組成物
JP5753958B2 (ja) 澄明な水性液剤
JP6267394B1 (ja) 水溶性粘稠化剤を含有する医薬組成物
JP6817877B2 (ja) ドルゾラミド、高分子およびホウ酸を含有する医薬組成物
EP4512404A1 (en) Composition for ophthalmic use containing sepetaprost
JP2022123792A (ja) 水性医薬組成物
JP7269425B2 (ja) 水性液剤
JP7792540B2 (ja) 水性液剤
JP2024090829A (ja) 滅菌容器に収容されるエピナスチン含有水性医薬組成物
WO2025079591A1 (ja) セペタプロストを含有する点眼液
JP2025520938A (ja) 注射用フェニレフリン組成物
HK40071854B (en) Pharmaceutical composition
JP2024052135A (ja) 水性液剤